Correlation Between Bone Biologics and BioAffinity Technologies,

Can any of the company-specific risk be diversified away by investing in both Bone Biologics and BioAffinity Technologies, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bone Biologics and BioAffinity Technologies, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Bone Biologics Corp and bioAffinity Technologies,, you can compare the effects of market volatilities on Bone Biologics and BioAffinity Technologies, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bone Biologics with a short position of BioAffinity Technologies,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bone Biologics and BioAffinity Technologies,.

Diversification Opportunities for Bone Biologics and BioAffinity Technologies,

-0.16

Correlation Coefficient

Bone Biologics  BioAffinity Technologies,

Good diversification

The 3 months correlation between Bone and BioAffinity is -0.16. Overlapping area represents the amount of risk that can be diversified away by holding Bone Biologics Corp and bioAffinity Technologies, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on bioAffinity Technologies, and Bone Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bone Biologics Corp are associated (or correlated) with BioAffinity Technologies,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of bioAffinity Technologies, has no effect on the direction of Bone Biologics i.e., Bone Biologics and BioAffinity Technologies, go up and down completely randomly.

Pair Corralation between Bone Biologics and BioAffinity Technologies,

Given the investment horizon of 90 days Bone Biologics Corp is expected to under-perform the BioAffinity Technologies,. But the stock apears to be less risky and, when comparing its historical volatility, Bone Biologics Corp is 1.64 times less risky than BioAffinity Technologies,. The stock trades about -0.16 of its potential returns per unit of risk. The bioAffinity Technologies, is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  27.00  in bioAffinity Technologies, on May 27, 2025 and sell it today you would lose (1.60) from holding bioAffinity Technologies, or give up 5.93% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Bone Biologics Corp  vs.  bioAffinity Technologies,

Bone Biologics Corp

Risk-Adjusted Performance

Weakest

Over the last 90 days Bone Biologics Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's essential indicators remain nearly stable which may send shares a bit higher in September 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

bioAffinity Technologies,

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in bioAffinity Technologies, are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, BioAffinity Technologies, reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Bone Biologics and BioAffinity Technologies,

The main advantage of trading using opposite Bone Biologics and BioAffinity Technologies, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bone Biologics position performs unexpectedly, BioAffinity Technologies, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioAffinity Technologies, will offset losses from the drop in BioAffinity Technologies,'s long position.

The idea behind Bone Biologics Corp and bioAffinity Technologies, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.